Please login to the form below

Not currently logged in
Email:
Password:

PharmaLex announces joint venture with Vintura

Partnership provides benefits for both organisations

PharmaLex

PharmaLex has entered into a joint venture with life sciences and healthcare strategic consultancy Vintura. 

The partnership will provide benefits for both organisations – Vintura will be able to access the expertise offered by PharmaLex's global reach in 31 offices across 17 countries, and PharmaLex is set to build on its service portfolio offering to clients with Vintura’s specialisms.

The two organisations will continue to operate under their respective, well-established brands.

"We are very excited to be joining forces with the PharmaLex Group," said Gérard Klop, partner at Vintura.

"PharmaLex has a very strong heritage in the life sciences sector and we see clear synergies between our two organisations. In addition, the international footprint of PharmaLex supports our international growth objectives," he added.

PharmaLex is a specialist service provider for the pharmaceutical industry, offering services for development consulting, regulatory affairs, quality management & compliance and pharmacovigilance.

Vintura is a strategy and organisation consultancy with speciality in healthcare and life sciences, and has offices based in Amsterdam, the Netherlands and Munich, Germany.

9th December 2019

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page and Partners

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....